Lion’s mane mushroom (Hericium erinaceus) has attracted considerable research attention for its effects on the nervous system. A smaller but growing body of literature now examines a distinct area: its potential role in supporting intestinal health. Preclinical studies suggest that compounds extracted from lion’s mane may influence gut inflammation, the integrity of the intestinal lining, and the composition of the gut microbiota. This article reviews what the current research shows and where important limitations remain.
The Compounds Under Investigation
Lion’s mane contains two primary classes of bioactive compounds. The first includes hericenones and erinacines, terpenoid molecules concentrated in the fruiting body and mycelium respectively, which have been studied primarily for their effects on nerve growth factor (NGF). The second class encompasses polysaccharides, particularly beta-1,3/1,6-glucans and heteroglycans, which have become the focus of gut-related research.
These polysaccharides largely resist digestion in the upper gastrointestinal tract, reaching the colon intact, where they may interact directly with intestinal epithelial cells and the local microbial population. Research suggests this structural characteristic is central to the observed effects in animal models of intestinal inflammation.
Animal Research on Ulcerative Colitis Models
The bulk of current evidence comes from rodent and primate studies using dextran sodium sulfate (DSS) or acetic acid-induced colitis models, both of which are widely used proxies for human inflammatory bowel conditions.
Effects on Inflammatory Pathways
In a 2024 study, polysaccharides extracted from H. erinaceus fruiting bodies were administered to mice with DSS-induced ulcerative colitis. Researchers observed significantly reduced levels of pro-inflammatory cytokines, including IL-6, IL-1β, and TNF-α, alongside elevated levels of anti-inflammatory IL-10. Western blot analyses indicated reduced expression of NLRP3 inflammasome components, including ASC and caspase-1, suggesting a mechanism involving suppression of the NLRP3/Caspase-1 inflammatory pathway.[1]
Separately, a 2026 study evaluated a beta-glucan-rich hot-water extract of H. erinaceus in both cell-based and mouse colitis models. The extract reduced pro-inflammatory cytokines and restored tight junction proteins, including occludin, ZO-1, and MUC2, in intestinal epithelial cells. In DSS-colitis mice, the extract improved disease activity indicators and reduced mucosal tissue damage on histological examination. Microbiome profiling showed the extract attenuated increases in specific inflammation-associated bacterial populations.[2]
Beyond Rodent Models: Primate Research
A 2023 study provided a higher-order model, examining H. erinaceus mycelium-derived polysaccharides in cynomolgus monkeys that developed spontaneous ulcerative colitis, a condition that more closely mimics human UC than chemically induced rodent models. Supplementation with the polysaccharide was associated with reduced intestinal inflammation markers, improved nutritional status, lower incidence of diarrhea, and favorable changes in gut microbiota composition.[3] The authors noted that this spontaneous primate model may offer advantages for translational research, though human clinical validation remains the necessary next step.
Epithelial Barrier Integrity
A recurring theme across the research is the role of lion’s mane extracts in supporting what researchers call “epithelial barrier integrity.” The intestinal lining relies on tight junction proteins to regulate what passes from the gut lumen into circulation. In inflammatory bowel conditions, this barrier can become compromised, contributing to the broader inflammatory cycle.
Studies indicate that H. erinaceus polysaccharides may help restore the expression of these tight junction proteins in damaged intestinal tissue. This effect has been observed in both cell culture models and animal studies, though the precise molecular signaling involved varies across experimental designs.
Gut Microbiota Modulation
Several studies report that lion’s mane extracts influence the relative abundance of specific bacterial genera in the gut. In the 2024 mouse study, the lion’s mane polysaccharide group showed higher abundance of genera including Lachnospiraceae, Parabacteroides, and Oscillibacter compared to controls.[1] The 2026 study observed selective remodeling of inflammation-associated microbial populations in DSS-treated mice receiving the extract.[2]
These microbiota-level changes are consistent with a broader pattern seen across several functional mushroom species. For context on how turkey tail polysaccharides influence the gut microbiome through similar prebiotic mechanisms, see Turkey Tail Mushroom and the Gut Microbiome: What Prebiotic Research Shows.
Critical Limitations of the Current Evidence
Several important caveats apply to the current body of research on lion’s mane and gut health:
- Animal models do not automatically translate to humans. DSS-induced colitis in rodents and chemically induced models have limited fidelity to the heterogeneous biology of human inflammatory bowel disease.
- Extract standardization varies widely. Studies use different extraction methods, molecular weights, and purity levels. A polysaccharide fraction from one preparation may behave differently from another, making direct comparisons difficult.
- Human clinical trials are absent in this specific area. While human trials exist for lion’s mane effects on cognition, controlled trials specifically examining gut or IBD outcomes in humans have not yet been published.
- Mechanism studies are primarily mechanistic, not outcome-based. Observing reduced inflammatory markers or altered microbiota in animal models does not confirm clinical benefit in human patients.
Context for Consumer Interest
Interest in lion’s mane for gut health has grown alongside broader awareness of functional mushrooms as prebiotic candidates. Polysaccharides from edible mushrooms in general, including lion’s mane, are fermented by colonic bacteria in ways that may support microbial diversity and short-chain fatty acid production. These are plausible mechanistic pathways, though the clinical significance in humans requires prospective studies to establish.
For individuals with diagnosed inflammatory bowel conditions, any supplementation decisions should involve discussion with a qualified gastroenterologist familiar with their specific disease profile and current treatment plan.
Summary
Preclinical research indicates that polysaccharide fractions from Hericium erinaceus may support gut health through several mechanisms, including modulation of the NLRP3 inflammasome pathway, restoration of intestinal barrier proteins, reduction of pro-inflammatory cytokines, and favorable shifts in gut microbiota composition. These findings span rodent and primate models, including a spontaneous primate UC model that may improve translational relevance. No human clinical trials have yet tested these specific outcomes. The research area is active, and findings to date justify further investigation, though current evidence is not sufficient to support clinical recommendations.
References
- [1] Li H, et al. Polysaccharides from Hericium erinaceus alleviate ulcerative colitis in mice by inhibiting the NLRP3 inflammasomes and reestablish intestinal homeostasis. Int J Biol Macromol. 2024;267(Pt 1):131251. PMID: 38556226
- [2] Yu H, et al. Beta-glucan-rich Hericium erinaceus hot-water extract ameliorates acute colitis by suppressing inflammation, preserving the epithelial barrier, and modulating gut microbiota ecosystem. Int J Biol Macromol. 2026;354:151368. PMID: 41819322
- [3] Ren Z, et al. Hericium erinaceus mycelium-derived polysaccharide alleviates ulcerative colitis and modulates gut microbiota in cynomolgus monkeys. Mol Nutr Food Res. 2023;67(3):e2200450. PMID: 36443636
Disclaimer: This article is for informational purposes only and does not constitute medical advice. The studies cited are preclinical in nature, and findings from animal models may not apply to humans. Do not use this content to diagnose, treat, or manage any health condition. Consult a qualified healthcare provider before adding any supplement to your routine, particularly if you have a diagnosed gastrointestinal condition or are taking medications.
